NASDAQ: PMCBPharmacyte Biotech Inc Stock Ownership - Who owns Pharmacyte Biotech?
Insider buying vs selling
Have Pharmacyte Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joshua Silverman | CEO and President | 2026-01-07 | 40,000 | $0.83 | $33.32kBuy |
| Jonathan Schechter | Director | 2026-01-07 | 20,000 | $0.84 | $16.88kBuy |
| Joshua Silverman | CEO and President | 2026-01-06 | 30,000 | $0.79 | $23.67kBuy |
| Jonathan Schechter | Director | 2026-01-06 | 20,000 | $0.79 | $15.80kBuy |
| Joshua Silverman | CEO and President | 2026-01-05 | 30,000 | $0.78 | $23.49kBuy |
| Jonathan Schechter | Director | 2026-01-05 | 20,000 | $0.78 | $15.56kBuy |
| Robert 1. Weinstein | Director | 2025-12-12 | 33,750 | $1.02 | $34.43kSell |
| Jonathan Schechter | Director | 2025-12-12 | 67,500 | $1.02 | $68.85kSell |
| Joshua Silverman | CEO and President | 2025-12-12 | 258,750 | $1.02 | $263.93kSell |
| Wayne Remell Walker | Director | 2025-12-12 | 16,875 | $1.02 | $17.21kSell |
PMCB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PMCB insiders and whales buy or sell their stock.
PMCB Shareholders
What type of owners hold Pharmacyte Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Daniel Stuart Farb | 6.66% | 714,570 | $321.56k | Insider |
| Joshua Silverman | 4.34% | 466,250 | $209.81k | Insider |
| Daniel Allen | 2.42% | 260,000 | $117.00k | Insider |
| Jonathan Schechter | 1.79% | 192,500 | $86.63k | Insider |
| Robert 1. Weinstein | 0.38% | 41,250 | $18.56k | Insider |
| Michael M. Abecassis | 0.22% | 23,092 | $10.39k | Insider |
| Wayne Remell Walker | 0.19% | 20,625 | $9.28k | Insider |
| Kenneth L. Waggoner | 0.19% | 20,600 | $9.27k | Insider |
| Gerald W. Crabtree | 0.10% | 11,200 | $5.04k | Insider |
| Carlos Trujillo | 0.08% | 8,800 | $3.96k | Insider |
PMCB vs Biotech Stocks
Pharmacyte Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.